A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Clinical trial NCT01908829 · COMPLETED
Trial details
- NCT number
- NCT01908829
- Sponsor
- Astellas Pharma Europe Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-10
- Primary completion
- 2014-11-24
- Enrollment
- 2174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.